Follow-UP Of Occluded Artery Trial

In a subset of patients suffering heart attack, adding stents to clot-busting medical therapy after the optimal treatment window ends isn’t justified, say researchers from Duke University Medical Center. [click link for full article]

More: continued here

Filed under: Cardiovascular on November 6th, 2007